Performance of commercial SARS-CoV-2 wild-type and Omicron BA.1 antibody assays compared with pseudovirus neutralization tests.
Journal Information
Full Title: J Clin Virol
Abbreviation: J Clin Virol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declaration of Competing Interest Euroimmun provided test kits for antibody testing free of charge as part of a research agreement. Otherwise, the authors declare that there are no conflicts of interest."
Funding Disclosure
Evidence found in paper:
"Parts of this work were supported by grants from COVIM: NaFoUniMedCovid19 (FKZ: 01KX2021) (to LES and FK), the Federal Institute for Drugs and Medical Devices (V2021.3 / 1503_68403 / 2021–2022) (to LES and FK) and the 10.13039/501100001659Deutsche Forschungsgemeinschaft (DFG) (SFB-TR84 to LES)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025